Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000500376 | SCV000597819 | uncertain significance | not specified | 2016-12-09 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000765202 | SCV000896437 | uncertain significance | Angelman syndrome | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000765202 | SCV004534604 | uncertain significance | Angelman syndrome | 2023-10-07 | criteria provided, single submitter | clinical testing | This sequence change replaces methionine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 317 of the UBE3A protein (p.Met317Leu). This variant is present in population databases (rs368318081, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with UBE3A-related conditions. ClinVar contains an entry for this variant (Variation ID: 437195). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt UBE3A protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |